45
Participants
Start Date
November 15, 2022
Primary Completion Date
January 1, 2027
Study Completion Date
December 31, 2027
Squaric Acid Dibutyl Ester
Sensitization dose: 2% Elicitation doses: {0.0001%, 0.00025%, 0.00075%, 0.001%, 0.0025%, 0.005%, 0.0075%, 0.01%, 0.025%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6% 0.7%, 0.8%, 0.9%, 1.0%, 1.2%, 1.4%, 1.6%, 1.8%, 2.0%}
Known patch test allergens
Positive patch test allergens during the course of clinical patch testing will be re-applied on the back followed by skin sampling
Dupilumab
300mg
Adalimumab
40mg
Ustekinumab
45mg
Guselkumab
100mg
Canakinumab
150mg
Sarilumab
200mg
Triamcinolone Acetonide
0.1% ointment
Betamethasone Valerate
0.1% ointment
Fluticasone Propionate
0.005% ointment
Microneedle
Painless and non-scarring skin sampling with a 7mm x 7mm patch of hydrogel-coated poly-l-lactide microneedles (\<2mm length) will be used to collect interstitial fluid
Suction blistering
Suction blistering is a technique to induce and collect blister fluid using a negative pressure instrument (Electronic Diversities Finksburg, MD). It does not require local anesthetic, stitches or pain medication following the procedure. The blisters will be no greater than 1cm in diameter and no deeper than the epidermis (\<1mm deep). This process of inducing blisters is typically less than 1 hour. After the formation of blisters, the blister fluid will be extracted using a syringe. The blister roofs will be left attached to the skin and covered with petrolatum and a bandage.
Skin punch biopsy
A skin biopsy is the removal of a small piece of tissue, under local anesthetic.
RECRUITING
University of Massachusetts Chan Medical School, Worcester
John Harris
OTHER